Senators grilled Novo Nordisk CEO Lars Jorgensen at a hearing on Tuesday about the cost of diabetes drug Ozempic and weight ...
What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.
While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...
If these preliminary findings are more widely applicable, opioid use disorder would be added to the long list of ailments potentially reduced by Ozempic.
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
Sen. Bernie Sanders (I-Vt.) has once again criticized Novo Nordisk A/S (NYSE:NVO) for the high price of its diabetes drug, ...